Last reviewed · How we verify
NCT03760133
The Change of Gut Microbiota After Bowel Preparation and the Effect of Probiotics
Phase 2 trial testing Duolac in Gut Microbiota in 100 participants. Completed in 31 December 2019.
30 November 2019
Quick facts
| Lead sponsor | Kosin University Gospel Hospital |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 100 |
| Start date | 1 December 2018 |
| Primary completion | 30 November 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Duolac — full drug profile →
Conditions studied
- Gut Microbiota — all drugs for Gut Microbiota →
- Bowel Preparation — all drugs for Bowel Preparation →
- Colonoscopy — all drugs for Colonoscopy →
Sponsor
Kosin University Gospel Hospital
Who can join
Adults 30 to 70, any sex, with Gut Microbiota or Bowel Preparation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate the relationship between the change of intestinal bacterial flora and the recovery, and the incidence of symptoms such as abdominal discomfort after colonoscopy. And the investigators will also analyze the effects of probiotics on the degree of change, recovery, and symptom development in intestinal flora.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03760133
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gut Microbiota
Currently open trials in the same condition.
- NCT07289581 — Effect of Treatment With Butyric Acid in Anorexia Nervosa · NA · active not recruiting
- NCT07214428 — Effects of Grape Powder on Psychological Distress and Gut Microbiota in College Students · NA · active not recruiting
- NCT07052071 — Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis · recruiting
- NCT06935435 — Effects of Distinct Nebraska-Dry Bean Market Classes on Gut Microbiota · NA · active not recruiting
- NCT06854536 — A Study on the Changes and Prognosis of Intestinal Microbiota and Function in Infants With Food Allergies · active not recruiting
Other Kosin University Gospel Hospital trials
Trials by the same sponsor.
- NCT03809780 — Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone · Phase 2 · unknown
- NCT03697356 — R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia · Phase 2 · recruiting
- NCT03054467 — Effect of Amlodipine Versus Amlodipine Combined With Atorvastatin on the Coronary Vasospastic Angina · Phase 4 · unknown
- NCT03153059 — Gut Microbiota and Stool Frequency · completed
- NCT03465527 — Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03760133 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kosin University Gospel Hospital
- Last refreshed: 20 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03760133.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing